A novel gene that regulates the K-toxin (plc), U-toxin (colA), and a-toxin (pfoA) genes was identified using toxin-negative mutant strains of Clostridium perfringens. The cloned 3.2-kb fragment contained the virX gene encoding a 51-amino acid polypeptide of unknown function that seemed to be responsible for the activation of toxin genes. The virX knock out mutant of wild-type strain 13 showed a reduced expression of the plc, colA, and pfoA genes, which was complemented by the transformation of the intact virX gene. Deletion and site-directed mutagenesis studies suggested that the virX gene acts as a regulatory RNA rather than as a peptide regulator. The virX locus found in this study might play a part in the signal transduction to regulate toxin production in C. perfringens. ß
Introduction
A Gram-positive anaerobic pathogen, Clostridium perfringens, is a causative agent of clostridial myonecrosis (gas gangrene) and mild diarrhea in humans [1, 2] . The organism produces numerous toxins and enzymes that act in concert to degrade various components of human tissues, resulting in a severe myonecrosis [3] . Understanding the genetic regulation of the expression of the virulence factors is important, since coordinated expression of the numerous virulence factors is presumably required for a synchronized development of infection by C. perfringens [4, 5] .
A two-component regulatory system, VirR/VirS, has been reported to regulate the expression of many virulence factors such as the K-toxin (plc), U-toxin (colA), and a-toxin (pfoA) genes in C. perfringens [4, 5] . Promoter analysis of the toxin genes identi¢ed the corresponding VirR/ VirS-regulated mRNA start sites [6] ; however, no similar DNA sequence to which the VirR protein would bind was found in the £anking regions of the promoters [6] . Formerly, three genes and one operon whose expression was regulated by the VirR/VirS system have been identi¢ed by di¡erential display experiments [7] . The ptp (protein tyrosine phosphatase), cpd (2P,3P-cyclic nucleotide 2P-phosphodiesterase), and hyp7 (hypothetical protein) genes were shown to be positively regulated, while the ycgJ-metBcysK-ygaG operon was negatively regulated by the VirR/ VirS system [7, 8] . Recently, we had found that VR-RNA transcribing the hyp7 gene is a regulatory RNA that regulates the expression of the plc and colA genes but not the pfoA gene [9] . Thus, the regulatory network for the toxin genes seems to be complicated, and an unknown regulatory system may be involved in the regulation of virulence factors in C. perfringens.
Here we report the cloning and characterization of a novel regulatory gene (virX) that regulates the plc, colA, and pfoA genes in C. perfringens. The results indicated that the regulatory function seems not to be related to the product of virX but to an RNA molecule itself transcribed from the virX gene.
Materials and methods
2.1. Strains, media, and culture conditions C. perfringens strains 13 [10] , SI112 [11] , TS133 [11] , TS186 (this study), and their derivative strains were cultured in GAM medium containing appropriate antibiotics at 37 ‡C under anaerobic conditions, as described previously [11] . Escherichia coli strain JM109 [12] was cultured under standard conditions [13] . Plasmid pUC19 was used for cloning in E. coli, and pJIR418 [14] was used as an E. coli^C. perfringens shuttle vector to transform C. perfringens strains by an electroporation as described [11] .
DNA manipulation
General recombinant DNA techniques were performed as described by Sambrook et al. [13] unless otherwise noted. The chromosomal DNA library of C. perfringens was constructed as described previously [11] . Site-directed mutagenesis was performed using a Takara LA PCR in vitro mutagenesis kit (Takara Shuzo, Japan). The nucleotide sequence of the fragments on pTS907 was determined by nucleotide sequencing with primer walking using a BigDye terminator reaction kit and ABI 310 sequencer (Applied Biosystems Japan). The mutations and deletion endpoints were also con¢rmed by nucleotide sequencing with appropriate primers.
Construction of the virX mutant
The 1.8-kb HindIII fragment of pTS902 was subcloned into pUC18 (pTS919), and the 1.1-kb PCR fragment ampli¢ed from the erythromycin resistance determinant (ermBP) of pJIR418 was subsequently inserted into the SmaI site of pTS919 (designated pTS921). Then, the 0.5-kb PCR fragment ampli¢ed from the downstream region of virX was inserted into the EcoRI site of pTS921. After checking the orientations of the fragments by sequencing, the resulting plasmid (pTS922) was transformed into C. perfringens strain 13 by electroporation, and the transformants were selected on BHI-sheep-blood agar plates containing 50 Wg ml 31 erythromycin.
Northern hybridization
Total RNA from C. perfringens was extracted as described previously [15] , and Northern hybridization was done according to the method described previously [6, 16] , with the exceptions that DNA fragments were labeled with an AlkPhos-direct kit (Amersham Pharmacia Biotech) and signals were detected by CDPstar chemiluminescence. The colA, plc, pfoA, and virX probes were prepared by PCR from pKY3135 [17] , pKB300 [18] , pTS310 [19] , and pTS907 (this study), respectively, using the appropriate primer sets.
Primer extension analysis
Primer extension experiments were performed basically as described previously [6] using a synthetic oligonucleotide primer, virX-2 (5P-TTTGAAGAATTCTTGTTCTC-CTACAGTGAATACGA-3P), with exceptions that the experiment was done using a 5P-oligolabeling for £uorescein kit (Amersham Pharmacia Biotech) and a primer extension system (Promega), and the signal was detected by a FluorImager image analyzer (Amersham Pharmacia Biotech).
Results and discussion

Isolation of a DNA fragment that restored toxin expression in strains SI112 and TS133
A chromosomal DNA library of C. perfringens strain 13 was transformed into the toxin-negative mutant strain SI112 that was isolated by nitrosoguanidine (NTG) treatment in the previous study [11] . One out of ca. 3000 transformants was found to restore the hemolytic activity and contained a 3.2-kb HindIII fragment on pJIR418 (designated pTS902). A restriction map of the fragment was totally di¡erent from that of the virR and virS genes [11] , indicating that pTS902 contained a novel regulatory gene(s) for the expression of hemolytic toxins such as K-and/or a-toxins. Subsequently, Northern analysis was carried out on strains 13, SI112, and SI112 harboring pTS902. Transcript for pfoA was scarcely detected in SI112, while the pfoA mRNA was apparently expressed in SI112 harboring pTS902 (Fig. 1A) . In addition, mRNAs for the plc and colA genes also increased with the transformation of pTS902 in SI112 (Fig. 1A) .
Since we could not identify the precise genetic background of the NTG-treated mutant SI112, we then introduced pTS902 into the virR mutant strain TS133 [11] and checked the transcription of toxin genes. The transcription of the colA and plc genes signi¢cantly increased in TS133 by the transformation of pTS902, while the pfoA gene was not expressed in TS133(pTS902) (Fig. 1B) , indicating that pTS902 carried a novel regulatory gene(s) that could activate the transcription of colA and plc in the absence of the VirR/VirS regulatory system in C. perfringens. Since the expression of pfoA has been thought to be totally dependent on the VirR/VirS system [6] , it is possible that the regulatory gene(s) on pTS902 requires the VirR/VirS system to activate the pfoA gene. We also noticed that the transcription of the toxin genes increased with the transformation of pTS902 both in SI112 and TS133 (Fig.  1A,B) , which indicates that the overexpression of the regulatory gene(s) on the multicopy plasmid (pTS902) results in the increased expression of the toxin genes in C. perfringens.
Nucleotide sequence analysis of pTS902
We subcloned the 1.8-and 1.4-kb HindIII fragments of pTS902 into pJIR418, and the resulting plasmids were separately transformed into SI112. The 1.4-kb HindIII fragment (pTS907, Fig. 2A) showed increased transcription of the toxin genes in strain SI112 (data not shown) and we determined the nucleotide sequence of the 1.4-kb fragment. Three putative open reading frames (ORFs 1, 2, 3) were found in this fragment ( Fig. 2A) . ORF2 (designated virX), located from position 663 to 818 with a putative ribosome-binding site, was the only ORF that seemed to be intact in pTS907 (Fig. 2A) . A homology search using the BLAST program [20] revealed that the deduced amino acid sequence of ORF3 had signi¢cant similarity with glutaminyl-tRNA synthetase (glnS) of E. coli, while we could not ¢nd any similar proteins to the ORF1 and virX products. We also determined the nucleotide sequence of the virX region that was cloned from the mutant strain SI112. However, the nucleotide sequence was not di¡erent from that of strain 13, indicating that the expected mutation(s) in SI112 that makes this strain nontoxigenic is not present in the virX region. In addition, the 0.4-kb transcript for virX was detected in SI112 (Fig. 1A) , which supports our conclusion that SI112 lacks a regulatory system for toxin production distinct from the virXmediated regulation. The transcription start site of the virX gene was determined by a primer extension experiment and was located at A in position 549 ( Fig. 2A,B) . The possible consensus promoter sequences (335 and 310) could be located upstream of the virX mRNA start site ( Fig. 2A) . The partial restriction and genetic map is shown at the top. A part of the nucleotide sequence of pTS907 is shown below with consensus promoter sequences (335 and 310) and transcription start sites deduced from the primer extension experiment. The portion indicated by underlines corresponds to the region required for the regulatory activity on the toxin genes deduced from the deletion experiments in Fig. 4 . The nucleotide sequence data of the virX region will appear in the DDBJ, EMB and GenBank nucleotide sequence databases with accession number AP003187. B: Primer extension analysis of virX. The primer extension product was electrophoresed on sequencing gels together with sequencing reactions using the same primers. The extended product is shown with an arrow.
Isolation of the virX mutant and expression of toxin genes in the mutant
To examine the precise role of the virX gene in C. perfringens, we constructed a mutant (TS186) of virX from strain 13 by a homologous recombination using pTS922 (see Section 2) . Southern analysis showed that the virX gene on the chromosome of TS186 was totally missing (data not shown), indicating that TS186 had a mutation in the virX locus by a double-crossing-over recombination.
We introduced pTS907 into the mutant strain TS186 and prepared total RNA from various growth phases, and Northern analysis was carried out with the pfoA, colA, plc, and virX gene probes (Fig. 3B) . We successfully detected a 0.4-kb virX mRNA in strain 13, while the virX transcript was not detected in TS186(pJIR418) (Fig. 3B) , indicating that there was no expression of the virX gene in TS186. The pfoA-speci¢c mRNA apparently decreased in TS186 but increased following the transformation of pTS907, which was apparent at 2^2.5 h of growth (midexponential phase) (Fig. 3A,B) . Transcriptions of colA and plc signi¢cantly decreased in strain TS186, while TS186 carrying pTS902 regained its ability to express these toxin genes, which was apparent at the late-exponential phase (3.5^4 h of growth) (Fig. 3A,B) . These data suggested that the virX gene positively regulated three toxin genes, although the timing of the regulatory e¡ects varied among the toxin genes.
Deletion analysis of pTS907
To determine the responsible region for the observed regulatory activity of virX, we generated several deletions of the 1.4-kb fragment and introduced the fragments into the mutant strain TS186 (Fig. 4) . The fragments containing the entire virX gene (pTS910 and pTS911) could activate the expression of plc, colA, and pfoA in the same manner as pTS907 in TS186 (Fig. 4, lanes 4 and 5) . Unexpectedly, the positive regulatory e¡ect on the toxin genes was also seen in pTS912, even though its virX-coding region was truncated (Fig. 4, lane 6) . Plasmid pTS916 that contained the promoter region of virX but lacked the whole virX gene failed to activate the toxin genes (Fig.  4, lane 7) , which excluded the possibility that the e¡ect of the complementation of virX on plasmids was not de- rived from the titration of possible regulatory factors which may bind to the virX promoter. Taken together, these data suggested that the intact virX-coding region might not be required for the regulatory function on toxin genes.
Site-directed mutagenesis of the virX gene
To clarify whether the 51-amino acid polypeptide encoded by the virX region is responsible for the regulatory function, we constructed plasmids that had nonsense mutations in the virX-coding region by a site-directed mutagenesis (Fig. 5A) . The resulting plasmids, pTS913, pTS914, and pTS915, still showed the same activity as the intact virX gene on pTS907, while the mRNAs of the mutated virX genes were properly expressed at the same level as in strain 13 (Fig. 5B, lanes 4^6 ). These results suggested that the virX transcript itself, but not any translated product from virX, might be responsible for the activation of toxin genes. We noticed that the transcriptions of the virX gene in TS186 harboring pTS913, pTS914, and pTS915 were signi¢cantly lower than that in TS186(pTS907) for reasons not understood at this time (Fig. 5B) , although their levels were at least the same as in the wild-type (lane 1).
The regulatory RNAs for virulence factors have been reported in Staphylococcus aureus and Streptococcus pyogenes, both of which are Gram-positive pathogens [21, 22] . In S. aureus, RNAIII is the direct e¡ector for the positive regulation of extracellular toxins and for the negative regulation of surface-expressed proteins [22] . The fasX transcript in S. pyogenes was reported to regulate ¢bronectin/ ¢brinogen-binding protein and other secreted virulence factors in a growth phase-dependent manner [21] . In addition, detailed analysis of the hyp7 gene [7] elucidated that the 0.4-kb transcript itself (VR-RNA) is the e¡ector for the regulation of plc and colA in C. perfringens [9] . Thus, the involvement of regulatory RNA in the regulation of virulence genes appears to be common to Gram-positive pathogenic bacteria.
In C. perfringens, multiple signal transduction systems might be involved in the regulation of extracellular toxin production to respond to various environmental changes. The virX locus found in this study might play a part of the signal transduction together with the VirR/VirS system. Further studies will be required to elucidate the details of the function of virX on the pathogenicity in this organism. 
